68

Micro Tech Nanjing Co Ltd

688029 · SHG · Healthcare / Medical Instruments & Supplies

84.51CNY+1.62 (+1.95%)

Price History

Full chart

Market Stats

Previous Close82.89
Open83.01
Day Range82.02 – 86.35
52-Week Range65.70 – 100.94
Volume2.83M
Market Cap16.30B
P/E (TTM)31.66
Forward P/E0.00
EPS2.74
Dividend Yield1.73%
Beta0.27
50-Day Avg76.23
200-Day Avg77.75

About

Micro-Tech (Nanjing) Co.,Ltd, together with its subsidiaries, engages in the research, development, manufacturing, and sale of minimally invasive medical devices in China and internationally. The company offers digestive endoscopy products, including ESD, such as electric flushing device, harmony/GT gold clip, gold/titanium knife, pull clamp, three-arm clap, hemostatic titanium forceps, injection needle, vascular clamp, spray pipe, electric oil, and indigo carmine muscosal staining agent; and ERCP comprising biliary duct drainage tube, nasobiliary drainage catheter, stone removal balloon, stone retrieval basket, level 3 balloon dilation catheter, guide wire, ruyi knife, and eyemax insights. It also provides hemostasis, which includes bandage and star king clip; dilation and biopsy, such as covered biliary stent, biliary stent, intestinal stent kit with biopsy access, intestinal stent, covered intestinal stent, segmented esophageal stent system, and covered esophageal stent kit; EUS comprising ultrasonic water bag and ultrasonic needle; cell brush; and net ring toss, cleaning brush, mouth pad, and foreign body forceps. In addition, the company offers interventional radiology and surgical devices. The company was founded in 2000 and is headquartered in Nanjing, China.

Company Details

  • SectorHealthcare
  • IndustryMedical Instruments & Supplies
  • CEOMr. Derong Leng
  • Employees2.37K
  • HeadquartersNo. 10, Gaoke Third Road, Nanjing, China, 210032, China
  • Websitehttps://www.micro-tech.com.cn

Leadership

  • Mr. Derong LengPresident & Director · b. 1963
  • Mr. Changqing LiExecutive President & Director · b. 1971
  • Mr. Chenwei RuiSenior VP, CFO & Chief Accountant · b. 1979
  • Mr. Jiefeng XiChief Scientist and Senior Director of R&D · b. 1982
  • Mr. Bo ZhangSenior VP & Director · b. 1970
  • Mr. Jian Yu WeiSenior Chief Engineer · b. 1980
  • Mr. Daniel KuhnSenior Vice President · b. 1960
  • Mr. Feng ZhangSenior Vice President · b. 1973
  • Mr. Gong XingliangVP & Secretary of the Board · b. 1973
  • Ms. Ning LiDirector of Quality & Regulatory Affairs · b. 1981

Financials

Income Statement

Currency: CNY2006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue24.79M42.49M61.72M81.65M107.63M127.36M169.11M202.66M260.69M414.31M640.67M922.11M1.31B1.33B1.95B1.98B2.41B2.76B3.19B
Growth (%)-+71.41%+45.27%+32.29%+31.82%+18.33%+32.78%+19.84%+28.63%+58.93%+54.64%+43.93%+41.79%+1.45%+46.77%+1.72%+21.78%+14.26%+15.81%
Cost of Revenue12.32M19.55M30.44M40.03M47.80M63.63M91.97M104.69M133.94M180.01M259.87M339.37M451.49M464.27M718.20M795.29M890.28M943.44M1.14B
Gross Profit12.47M22.94M31.28M41.62M59.84M63.73M77.14M97.97M126.75M234.30M380.80M582.73M855.99M862.14M1.23B1.18B1.52B1.81B3.19B
Gross Margin50.31%54.00%50.68%50.97%55.59%50.04%45.62%48.34%48.62%56.55%59.44%63.20%65.47%65.00%63.11%59.84%63.08%65.76%100.00%
Operating Expense4.52M7.27M10.26M13.47M25.27M30.88M55.96M66.89M87.53M248.67M249.06M354.05M504.46M579.91M861.34M820.69M966.52M1.15B2.50B
Operating Income7.95M15.67M21.03M28.16M34.56M32.85M21.18M31.07M39.22M-14.37M131.74M228.69M351.52M282.23M367.18M364.16M554.67M659.41M692.34M
Operating Margin32.07%36.89%34.06%34.48%32.11%25.79%12.53%15.33%15.04%-3.47%20.56%24.80%26.89%21.28%18.86%18.39%23.00%23.93%21.70%
EBITDA7.75M16.07M22.41M31.25M35.82M36.39M34.69M40.02M49.45M2.51M142.81M256.55M384.25M331.72M418.62M426.77M632.57M732.24M753.91M
EBITDA Margin31.27%37.81%36.30%38.27%33.28%28.57%20.51%19.75%18.97%0.61%22.29%27.82%29.39%25.01%21.50%21.55%26.23%26.57%23.63%
Net Income7.28M14.12M17.79M24.21M32.04M31.75M24.89M29.28M31.31M-36.45M101.18M192.70M303.60M260.76M324.75M330.59M485.92M553.23M570.11M
Net Income Margin29.38%33.23%28.82%29.65%29.77%24.93%14.72%14.45%12.01%-8.80%15.79%20.90%23.22%19.66%16.68%16.70%20.15%20.08%17.87%
R&D------5.57M7.43M5.57M17.80M37.86M49.12M70.40M99.67M152.89M165.33M150.80M174.37M199.05M
R&D as % of Total Revenue------3.29%3.67%2.14%4.30%5.91%5.33%5.38%7.51%7.85%8.35%6.25%6.33%6.24%
Interest Expense23.55K110.00K398.28K630.29K675.63K2.45M-103.21K939.32K4.67M06.87M5.89M4.31M4.67M6.62M8.37M11.06M4.54M
Interest Expense % of Total Revenue0.10%0.26%0.65%0.77%0.63%1.93%-0.05%0.36%1.13%0.00%0.75%0.45%0.33%0.24%0.33%0.35%0.40%0.14%

Balance Sheet

Currency: CNY2006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets30.77M51.88M67.20M88.16M141.34M178.31M287.74M326.95M464.73M540.50M718.33M969.22M2.88B3.11B3.63B3.89B4.39B4.78B5.46B
Total Liabilities11.39M21.38M23.15M24.56M55.69M61.17M54.67M64.59M164.55M181.57M252.14M348.85M347.16M441.59M641.44M619.55M722.51M880.24M-4.24B
Total Equity19.33M30.45M44.05M63.61M85.66M117.14M232.90M262.19M283.59M334.54M435.73M579.70M2.48B2.61B2.94B3.23B3.61B3.83B4.24B
Cash10.22M17.88M22.31M37.93M53.14M51.17M59.56M90.20M68.54M118.35M173.24M340.56M646.77M645.42M1.16B1.88B1.21B1.89B1.44B
Total Debt1.22M1.22M166.00K586.00K29.70M28.71M--45.00M70.00M96.05M96.23M-22.67M14.38M11.88M35.92M88.98M-
Net Debt-9.00M-16.66M-22.14M-37.34M-23.44M-22.46M-59.56M-90.20M-23.54M-48.35M-77.19M-244.33M-646.77M-622.76M-1.15B-1.86B-1.16B-1.80B-

Cash Flow

Currency: CNY2007-12-312008-12-312009-12-312010-12-312011-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow16.26M14.50M28.61M13.87M16.65M-6.76M49.59M10.23M79.98M140.48M192.32M252.49M231.27M172.89M250.14M545.57M613.02M687.95M
Investing Cash Flow-6.34M-2.85M-8.54M-14.43M-13.48M-63.00M3.20M-65.47M-69.45M-100.24M-26.30M-1.39B-163.10M245.81M668.59M-1.21B412.37M-
Financing Cash Flow-3.00M-5.31M-4.38M15.65M-2.48M-832.61K34.44M34.75M-13.88M-4.72M1.47B-51.68M-66.02M-73.76M-114.49M-357.48M-
Capital Expenditure6.83M3.34M9.14M14.91M13.37M19.62M41.81M41.75M35.83M53.43M48.77M53.47M162.11M164.75M213.38M256.09M269.62M254.93M
Free Cash Flow9.43M11.16M19.47M-1.04M3.28M-26.38M7.78M-31.52M44.15M87.04M143.55M199.02M69.16M8.14M36.76M289.48M400.20M433.02M
Dividends Paid3.00M4.23M4.80M10.01M1.30M--10.56M20.80M3.83M4.23M52.21M133.34M80.00M100.31M104.69M280.81M282.30M
FCF to OCF58.01%76.95%68.06%-7.48%19.71%390.44%15.69%-307.95%55.20%61.96%74.64%78.82%29.91%4.71%14.70%53.06%65.28%62.94%
Dividend Paid to FCF31.82%37.90%24.65%-964.46%39.67%---33.49%47.12%4.40%2.95%26.24%192.79%983.14%272.86%36.17%70.17%65.19%

Earnings

Report DateAug 28, 2019Oct 27, 2019Feb 27, 2020Apr 28, 2020Aug 17, 2020Oct 27, 2020Feb 26, 2021Apr 20, 2021Aug 25, 2021Oct 27, 2021Apr 25, 2022Aug 18, 2022Oct 27, 2022Apr 25, 2023Aug 7, 2023
EPS Estimate0.00--------------
EPS Actual0.290.770.490.360.360.510.280.500.410.560.230.440.220.540.87
Surprise---------------
TimingAfter-hoursPre-marketPre-marketAfter-hoursPre-marketAfter-hoursPre-marketPre-marketAfter-hoursPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-market

Key Statistics & Ratios

Market Cap16.30B
Enterprise Value14.83B
Trailing P/E31.66
Forward P/E0.00
Price / Sales4.87
Price / Book3.81
EPS2.74
Book Value22.44
Revenue (TTM)3.35B
Gross Profit (TTM)2.11B
EBITDA745.42M
Profit Margin15.25%
Operating Margin23.93%
Return on Equity11.90%
Return on Assets7.79%
Shares Outstanding187.85M
Shares Float97.67M
Beta0.27
Dividend Yield1.73%
Dividend Rate1.50
Payout Ratio54.74%

Dividends

20231×
0.55Jun 7, 2023
20221×
0.75Jun 10, 2022
20211×
0.43May 27, 2021
20201×
0.71May 12, 2020

Stock Splits

  • Jun 10, 2022188394:134567